No pathogenic mutations in the β-synuclein gene in Parkinson's disease-Reference-Cited by-同舟云学术

No pathogenic mutations in the β-synuclein gene in Parkinson's disease

Published:1999-07 Issue:2 Volume:269 Page:107-109
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Lincoln Sarah,Crook Richard,Chartier-Harlin Marie Christine,Gwinn-Hardy Katrina,Baker Matt,Mouroux Vincent,Richard Florence,Becquet Estelle,Amouyel Philippe,Destée Alain,Hardy John,Farrer Matt

Publisher

Elsevier BV

Subject

General Neuroscience

Reference8 articles.

1. Diagnostic criteria for Parkinson's disease;Gelb;Arch. Neurol.,1999

2. Ala30Pro mutation in the gene encoding [alpha]-synuclein in Parkinson's disease;Kruger;Nat. Genet,1998

3. Review: the Synuclein family;Lavedan;Genome Res.,1998

4. Genomic organization and expression of the human β-synuclein gene (SNCB);Lavedan;Genomics,1998

5. No pathogenic mutations in the persyn gene in Parkinson's disease;Lincoln;Neurosci. Lett.,1999

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity;Human Molecular Genetics;2021-07-12

2. Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons;Journal of Biological Chemistry;2021-01

3. Genetics of synucleins in neurodegenerative diseases;Acta Neuropathologica;2020-08-01

4. INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?1;Journal of Alzheimer's Disease;2018-08-07

5. Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease;Current Drug Metabolism;2014-03-31